$ATEX

Kuhn Thomas R. sold $1.0M of ATEX

Kuhn Thomas R. sold 11,654 shares of Anterix Inc. (ATEX) at an average of $87.53 ($79.52–$91.01, $1.02M total) across 5 trades over 2026-06-18 to 2026-08-24.

Original reporting
SEC EDGAR · Kuhn Thomas R.
Published Aug 26, 2026, 8:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 9:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ATEX
Bearish
medium confidence
Mentioned
$ATEX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATEXBearishLow
01

Why it matters

The disclosed sale provides fresh data on insider holdings, offering a modest trading cue for ATEX.

02

Market read

Primary insider sale filing; modest relevance for short‑term traders of ATEX.

03

What to watch

Potential upcoming financing needs or personal tax planning could explain the sale without implying company weakness.

Relevance 6/10Novelty 5/10Timing: filed 2026‑08‑26

Background

Form 4 filings disclose insider transactions; investors monitor them for signals about management confidence.

Company-level read

Ticker impact

$ATEXBearishMedium confidence
Context

Director Thomas R. Kuhn sold ~1 M USD of ATEX shares via open‑market trades, reducing his holding to 17,731 shares.

Expected impact

Modest downside pressure; possible 2‑3% dip over the next few days.

Evidence & confidence

A $1 M sale by a director is material for a micro‑cap like ATEX, but the amount is modest relative to market cap, so impact is limited.

Market effects

Minimal; insider activity unlikely to affect the broader telecom equipment sector.

None; ATEX trades primarily on US exchanges.

Low; the filing is company‑specific.

Counterpoint

The sale could be a routine liquidity move, not a negative signal; price may remain stable.

Key entities

  • Anterix Inc.

    Issuer of the ATEX ticker, a provider of wireless network solutions.

  • Thomas R. Kuhn

    Director of Anterix who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATEXMed

Is Anterix (ATEX) Quietly Reframing Its Connectivity Moat With New 900 MHz FCC Flexibility?

Anterix (ATEX) gained attention after the FCC approved expanded 900 MHz broadband use and granted it a license for satellite testing. This could broaden its network applications and reinforce its investment narrative, though profitability currently relies heavily on noncash spectrum gains. Analysts project $6.9M revenue and $935K earnings by 2028, with a potential 36% downside from current prices.

$ATEXMed

Anterix (ATEX) Q1 2027 Earnings Call Transcript

Anterix (ATEX) reported Q1 2027 revenue of $2M, up from $1.4M YoY, with net income of $240K. Operating expenses decreased to $12.9M. The company has $116M in cash, no debt, and $226.7M left for share repurchases. Management highlighted 12 active deals, spectrum clearing progress, and support for SpaceX's FCC proposal. CFO warned of potential higher costs if spectrum clearing is accelerated.

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Anterix Inc. Reports First Quarter Fiscal Year 2027 Results Woodland Park, NJ – August 11, 2026 – Anterix (NASDAQ: ATEX) today announced its first quarter fiscal 2027 results and filed its Form 10-Q for the three months ended June 30, 2026. Financial and Operational Highlights –

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atex-20260331xpressrelease.htm EX-99.1 Document Anterix Inc. Reports Full Fiscal Year 2026 Results Woodland Park, NJ – June 10, 2026 – Anterix (NASDAQ: ATEX) today announced fiscal 2026 fourth quarter and full fiscal year financial results for the year ended March 31, 2